Near future
Contacts
  • Home
  • Tech
  • Health
  • Environment
  • Architecture
  • energia
  • Transportation
  • Spazio
  • AI
  • concepts
  • Gadgets
  • Italy Next
  • H+
May 21, 2022

Coronavirus / Russia-Ukraine

Near future

News to understand, anticipate, improve the future.

No Result
View All Result

News to understand, anticipate, improve the future.

Read in:  Chinese (Simplified)EnglishFrenchGermanItalianJapanesePortugueseRussianSpanish

Micro "drug factories" implanted in mice eliminate tumors in 7 days

These "factories" capable of continuously delivering the drug in a targeted manner were injected into mice and cured colorectal and ovarian cancers in just under a week.

Gianluca Ricciodi Gianluca Riccio
in Medicine
Share97Pin23Tweet61SendShare17ShareShare12
amanda nash and omid veiseh

Study authors Amanda Nash and Omid Veiseh with their "drug factories"

March 3 2022
⚪ Reads in 3 minutes
A A

The difficulty of getting cancer medicines in the right places and in the right quantities is just one of the many obstacles that slow cancer treatments. A new type of implant developed at Rice University solves both problems by transporting tiny "cellular machines" that produce and distribute continuous doses of anti-cancer chemicals that can completely remove ovarian tumors in mice in just one week.

The researchers who created this intriguing new type of immunotherapeutic cancer therapy have dubbed them "drug factories" because once installed, they can produce the chemicals themselves needed to get rid of tumors. Implants are made up of tiny balls the size of a pinhead: they contain carefully selected cells encapsulated in a protective envelope.

The research was published in the journal Science Advances.

Drug factories

amanda nash drug factories
Amanda Nash, Rice University bioengineer working on new types of cancer treatment described as "drug factories"

These spheroidal particles are made to produce a natural chemical called interleukin-2, a cytokine that prompts white blood cells to come into action in the body's effort to fight cancer.

Maybe you are also interested

Vaxinia, first patient receives oncolytic virus that kills cancer

A 'ketogenic' molecule hinders colorectal cancer

A nano-drug precisely attacks chemotherapy-resistant cancer

Pancreatic Cancer: Technique reveals early stage cancer in 95% of cases

These beads were first tested in recent laboratory tests. The researchers 'tossed' them into malignant tumors within the peritoneum, the membrane that lines the abdominal cavity. Here, drug factories have been shown to selectively generate a concentration of interleukin-2 within tumors, without ending up elsewhere.

The experiments carried out

The first evidence was followed by research in mouse models of advanced ovarian and colorectal tumors. The spheres made a splash, demolishing tumors in rodents in just under a week. Most importantly, they delivered only high dosages of the drugs directly to the tumor site, avoiding toxicity to healthy cells.

“We only administer them once, but drug factories continue to distribute what is needed, where it is needed. Until the cancer is eliminated, ”he says Omid Veiseh, assistant professor of bioengineering. 

Once we discovered the correct dosage of "factories" to use, the results arrived. We got rid of the tumors in 100% of animals with ovarian cancer and seven out of eight with colorectal cancer.

What is the key factor of this solution?

Protective wrapping plays a crucial role in drug factories, and not just in keeping their contents safe. This shell is constructed of materials that the body perceives as foreign, but only as a potential danger to be faced after a set period of time. Consequently, the therapy does not continue indefinitely.

“We found that the foreign body reactions effectively and safely blocked the release of cytokines from the capsules after 30 days,” says Veiseh. "Furthermore, we have shown that even a second course of therapy can be safely administered, should it be needed."

When they set out to build these tiny pharmaceutical labs, the scientists were concerned about using only components that have already been proven safe for human use. L'interleukin-2 is an FDA-approved anticancer therapy, and this new technology of delivering high doses directly to tumor sites creates a more robust immune response.

In this study, we demonstrated that 'drug factories' allow for adjustable local administration of interleukin-2 and tumor eradication in several mouse models. This makes us excited about clinical trials.

Amir Jazaeri, co-author of the study

This technique, they say at Rice University, can be used against other malignant tumors: it is enough to set up the spheres of the 'drug factories' with different types of cells to elicit various immunological responses.

Human clinical trials of drug factories should start as early as 2022.

tags: cancer
Previous post

The hybrid photovoltaic system produces electricity and water in the desert

Next Post

Electric bikes: French startup creates repairable battery in less than 10 minutes

COLLABORATE

To submit articles, disclose the results of a research or scientific discoveries write to the editorial staff
  • Domus trimaran

    Domus, crazy zero-emission trimaran

    11698 Shares
    Share 4677 Tweet 2923
  • Plastic recycling, shock report: "it doesn't work, and it will never work"

    4354 Shares
    Share 1741 Tweet 1088
  • Create 'renewable' or rather 'perpetual' bio photovoltaic cells

    8231 Shares
    Share 3291 Tweet 2057
  • Hermeus tries it: hypersonic planes of 6000 kilometers per hour

    2348 Shares
    Share 939 Tweet 587
  • Unreal Engine 5, crazy: it doesn't stand out from reality

    5833 Shares
    Share 2333 Tweet 1458

archive

Have a look here:

Epstein Barr virus
Medicine

New vaccine for Epstein Barr virus: human experimentation begins

A new vaccine against Epstein Barr virus (EBV) will soon be tested in humans. If it works, it will protect against mononucleosis and ...

Read More

A folding drone closes in flight in confined spaces

POST FP 700X500 2022 05 09T112951.511

DARPA launches MAGIC AI, augmented reality glasses for military doctors

We missed the photo of the Chinese nuclear submarine in the underwater base

sonogenetics

Goodbye implants: sonogenetics controls brain cells from a distance

Next Post
repairable electric batteries

Electric bikes: French startup creates repairable battery in less than 10 minutes

The daily tomorrow

Futuroprossimo.it provides news on the future of technology, science and innovation: if there is something that is about to arrive, here it has already arrived. FuturoProssimo is part of the network ForwardTo, studies and skills for future scenarios.

Subscribe to our newsletter

Environment
Architecture
Artificial intelligence
Gadgets
concepts
Design

Staff
Archives
Advertising
Privacy Policy

Medicine
Spazio
Robotica
Work
Transportation
energia

To contact the FuturoProssimo editorial team, write to redazione@futuroprossimo.it

Chinese Version
Édition Française
Deutsche Ausgabe
Japanese version
English Edition
Edição Portuguesa
Русское издание
Spanish edition

The daily tomorrow

Futuroprossimo.it provides news on the future of technology, science and innovation: if there is something that is about to arrive, here it has already arrived. FuturoProssimo is part of the network ForwardTo, studies and skills for future scenarios.

Chinese Version
Édition Française
Deutsche Ausgabe
Japanese version
English Edition
Edição Portuguesa
Русское издание
Spanish edition

Staff
Archives
Advertising
Privacy Policy

Subscribe to our newsletter

To contact the FuturoProssimo editorial team, write to redazione@futuroprossimo.it

Categories

This work is distributed under license Creative Commons Attribution 4.0 International.
© 2021 Futuroprossimo

No Result
View All Result
  • Home
  • Tech
  • Health
  • Environment
  • Architecture
  • energia
  • Transportation
  • Spazio
  • AI
  • concepts
  • Gadgets
  • Italy Next
  • H+
This site uses cookies. By continuing to read it, you consent to their use.